Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression.

Jin Z, Zhao C, Han X, Han Y.

BMC Cancer. 2012 Oct 18;12:480. doi: 10.1186/1471-2407-12-480.

2.

SFRP5 inhibits gastric epithelial cell migration induced by macrophage-derived Wnt5a.

Zhao C, Ma H, Bu X, Wang W, Zhang N.

Carcinogenesis. 2013 Jan;34(1):146-52. doi: 10.1093/carcin/bgs309. Epub 2012 Oct 10.

PMID:
23054609
3.

GEC-derived SFRP5 inhibits Wnt5a-induced macrophage chemotaxis and activation.

Zhao C, Bu X, Wang W, Ma T, Ma H.

PLoS One. 2014 Jan 8;9(1):e85058. doi: 10.1371/journal.pone.0085058. eCollection 2014.

4.

Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration.

Ghosh MC, Collins GD, Vandanmagsar B, Patel K, Brill M, Carter A, Lustig A, Becker KG, Wood WW 3rd, Emeche CD, French AD, O'Connell MP, Xu M, Weeraratna AT, Taub DD.

Blood. 2009 Aug 13;114(7):1366-73. doi: 10.1182/blood-2008-08-175869. Epub 2009 Jun 11.

5.

Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.

Yamamoto H, Kitadai Y, Yamamoto H, Oue N, Ohdan H, Yasui W, Kikuchi A.

Gastroenterology. 2009 Jul;137(1):242-52, 252.e1-6.

PMID:
19582886
6.

Wnt5a activates THP-1 monocytic cells via a β-catenin-independent pathway involving JNK and NF-κB activation.

Kim J, Chang W, Jung Y, Song K, Lee I.

Cytokine. 2012 Oct;60(1):242-8. doi: 10.1016/j.cyto.2012.06.013. Epub 2012 Jul 2.

PMID:
22763043
7.

Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.

Jin F, Qu X, Fan Q, Wang L, Tang T, Hao Y, Dai K.

Mol Med Rep. 2013 Nov;8(5):1486-92. doi: 10.3892/mmr.2013.1698. Epub 2013 Sep 23.

PMID:
24064566
8.

Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation.

Catalán V, Gómez-Ambrosi J, Rodríguez A, Pérez-Hernández AI, Gurbindo J, Ramírez B, Méndez-Giménez L, Rotellar F, Valentí V, Moncada R, Martí P, Sola I, Silva C, Salvador J, Frühbeck G.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1407-17. doi: 10.1210/jc.2014-1191. Epub 2014 May 19.

PMID:
24840810
9.

WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.

Li J, Ying J, Fan Y, Wu L, Ying Y, Chan AT, Srivastava G, Tao Q.

Cancer Biol Ther. 2010 Sep 15;10(6):617-24. Epub 2010 Sep 7.

PMID:
20603606
10.

Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.

Prgomet Z, Axelsson L, Lindberg P, Andersson T.

J Oral Pathol Med. 2015 Nov;44(10):776-84. doi: 10.1111/jop.12292. Epub 2014 Dec 2.

PMID:
25459554
11.

WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.

Ekström EJ, Bergenfelz C, von Bülow V, Serifler F, Carlemalm E, Jönsson G, Andersson T, Leandersson K.

Mol Cancer. 2014 Apr 26;13:88. doi: 10.1186/1476-4598-13-88.

12.

Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma.

Bi L, Liu X, Wang C, Cao Y, Mao R, Li P, Geng M.

Int J Clin Exp Pathol. 2014 Feb 15;7(3):987-95. eCollection 2014.

13.

Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects.

Schulte DM, Müller N, Neumann K, Oberhäuser F, Faust M, Güdelhöfer H, Brandt B, Krone W, Laudes M.

PLoS One. 2012;7(2):e32437. doi: 10.1371/journal.pone.0032437. Epub 2012 Feb 23.

14.

Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.

Trifa F, Karray-Chouayekh S, Jmal E, Jmaa ZB, Khabir A, Sellami-Boudawara T, Frikha M, Daoud J, Mokdad-Gargouri R.

Tumour Biol. 2013 Jun;34(3):1625-33. doi: 10.1007/s13277-013-0694-2. Epub 2013 Feb 16.

PMID:
23417837
15.

Wnt5a induces endothelial inflammation via beta-catenin-independent signaling.

Kim J, Kim J, Kim DW, Ha Y, Ihm MH, Kim H, Song K, Lee I.

J Immunol. 2010 Jul 15;185(2):1274-82. doi: 10.4049/jimmunol.1000181. Epub 2010 Jun 16.

16.

Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.

Bakker ER, Das AM, Helvensteijn W, Franken PF, Swagemakers S, van der Valk MA, ten Hagen TL, Kuipers EJ, van Veelen W, Smits R.

Carcinogenesis. 2013 Nov;34(11):2629-38. doi: 10.1093/carcin/bgt215. Epub 2013 Jun 12.

PMID:
23764752
17.

PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration.

Liu J, Zhang Y, Xu R, Du J, Hu Z, Yang L, Chen Y, Zhu Y, Gu L.

Cell Signal. 2013 Feb;25(2):447-56. doi: 10.1016/j.cellsig.2012.10.012. Epub 2012 Oct 31.

PMID:
23123500
18.

Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma.

Krook MA, Nicholls LA, Scannell CA, Chugh R, Thomas DG, Lawlor ER.

Mol Cancer Res. 2014 Jun;12(6):953-64. doi: 10.1158/1541-7786.MCR-13-0668. Epub 2014 Mar 20.

19.

C-Jun N-terminal kinase (JNK) mediates Wnt5a-induced cell motility dependent or independent of RhoA pathway in human dental papilla cells.

Wang C, Zhao Y, Su Y, Li R, Lin Y, Zhou X, Ye L.

PLoS One. 2013 Jul 3;8(7):e69440. doi: 10.1371/journal.pone.0069440. Print 2013.

20.

Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.

Xie Q, Chen L, Shan X, Shan X, Tang J, Zhou F, Chen Q, Quan H, Nie D, Zhang W, Huang AL, Tang N.

Int J Cancer. 2014 Aug 1;135(3):635-46. doi: 10.1002/ijc.28697. Epub 2014 Jan 13.

Supplemental Content

Support Center